Csenge Advisory Group’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,950
| Closed | -$233K | – | 763 |
|
|
2025
Q4 | $233K | Sell |
2,950
-581
| -16% | -$45.6K | 0.01% | 651 |
|
|
2025
Q3 | $282K | Buy |
3,531
+246
| +7% | +$21K | 0.01% | 556 |
|
|
2025
Q2 | $305K | Sell |
3,285
-47
| -1% | -$4.29K | 0.02% | 553 |
|
|
2025
Q1 | $318K | Sell |
3,332
-377
| -10% | -$33.8K | 0.02% | 515 |
|
|
2024
Q4 | $337K | Sell |
3,709
-181
| -5% | -$17.3K | 0.02% | 527 |
|
|
2024
Q3 | $389K | Buy |
3,890
+156
| +4% | +$15.9K | 0.02% | 488 |
|
|
2024
Q2 | $362K | Buy |
3,734
+300
| +9% | +$27.7K | 0.02% | 485 |
|
|
2024
Q1 | $309K | Buy |
3,434
+31
| +0.9% | +$2.63K | 0.02% | 536 |
|
|
2023
Q4 | $271K | Sell |
3,403
-80
| -2% | -$6.01K | 0.02% | 546 |
|
|
2023
Q3 | $248K | Sell |
3,483
-152
| -4% | -$11.4K | 0.02% | 531 |
|
|
2023
Q2 | $280K | Buy |
3,635
+61
| +2% | +$4.72K | 0.02% | 518 |
|
|
2023
Q1 | $269K | Sell |
3,574
-19
| -0.5% | -$1.41K | 0.02% | 489 |
|
|
2022
Q4 | $283K | Sell |
3,593
-796
| -18% | -$59.7K | 0.02% | 478 |
|
|
2022
Q3 | $308K | Sell |
4,389
-194
| -4% | -$15.2K | 0.03% | 458 |
|
|
2022
Q2 | $367K | Sell |
4,583
-317
| -6% | -$24.8K | 0.03% | 401 |
|
|
2022
Q1 | $372K | Sell |
4,900
-2,773
| -36% | -$220K | 0.03% | 442 |
|
|
2021
Q4 | $627K | Buy |
7,673
+2,397
| +45% | +$187K | 0.06% | 289 |
|
|
2021
Q3 | $399K | Sell |
5,276
-2,397
| -31% | -$190K | 0.03% | 413 |
|
|
2021
Q2 | $627K | Buy |
7,673
+2,213
| +41% | +$181K | 0.06% | 290 |
|
|
2021
Q1 | $436K | Sell |
5,460
-1,225
| -18% | -$96K | 0.04% | 308 |
|
|
2020
Q4 | $572K | Sell |
6,685
-96
| -1% | -$7.94K | 0.07% | 206 |
|
|
2020
Q3 | $526K | Buy |
6,781
+405
| +6% | +$30.9K | 0.07% | 210 |
|
|
2020
Q2 | $467K | Sell |
6,376
-542
| -8% | -$38.5K | 0.07% | 212 |
|
|
2020
Q1 | $459K | Sell |
6,918
-327
| -5% | -$23.1K | 0.12% | 155 |
|
|
2019
Q4 | $499K | Buy |
7,245
+1,798
| +33% | +$123K | 0.13% | 156 |
|
|
2019
Q3 | $400K | Buy |
5,447
+765
| +16% | +$55.5K | 0.11% | 168 |
|
|
2019
Q2 | $335K | Sell |
4,682
-29
| -0.6% | -$2.06K | 0.11% | 136 |
|
|
2019
Q1 | $322K | Buy |
4,711
+5
| +0.1% | +$323 | 0.11% | 138 |
|
|
2018
Q4 | $280K | Buy |
4,706
+265
| +6% | +$16.6K | 0.1% | 144 |
|
|
2018
Q3 | $277K | Sell |
4,441
-3,110
| -41% | -$207K | 0.11% | 126 |
|
|
2018
Q2 | $487K | Buy |
7,551
+163
| +2% | +$10.7K | 0.18% | 121 |
|
|
2018
Q1 | $530K | Buy |
7,388
+1,404
| +23% | +$101K | 0.18% | 124 |
|
|
2017
Q4 | $452K | Buy |
5,984
+631
| +12% | +$46.1K | 0.16% | 116 |
|
|
2017
Q3 | $390K | Buy |
+5,353
| New | +$386K | 0.15% | 137 |
|
Other funds holding CL
Csenge Advisory Group's CL Position: Q1 2026 in Review
Csenge Advisory Group sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 2,950 shares — an estimated $233K sold.
Csenge Advisory Group first reported a position in CL in Q3 2017 and held it in 34 quarters. The position peaked at $627K in Q4 2021. 1,961 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Csenge Advisory Group reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
- Csenge Advisory Group sold 2,950 Colgate-Palmolive shares in Q1 2026, an estimated $233K.
- Csenge Advisory Group first reported a position in Colgate-Palmolive in Q3 2017 and held it in 34 quarters.
- Csenge Advisory Group's Colgate-Palmolive position peaked at $627K in Q4 2021.
- 1,961 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Csenge Advisory Group's 13F filing for Q1 2026, filed 30 Apr 2026.